Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...

Argobio successfully facilitated fundraising and syndication process, following its earlier role in creating and pre-seed funding EnodiaFinancing ...

Enodia Therapeutics has raised €20.7m ($25m) in seed funding to advance a small-molecule platform for targeted protein ...

A public database containing millions of predicted protein structures generated by a machine learning program could speed drug discovery, vaccine development and more. Understanding proteins — like ...

Sanofi has returned to U.S. artificial intelligence research biotech Earendil Labs for another significant autoimmune and ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Over the past two years, machine learning has revolutionized protein structure prediction. Now there's a similar revolution in protein design. Biologists show that machine learning can be used to ...

Understanding proteins — like the spike protein of the coronavirus — is superimportant for the study of diseases and the development of drugs and vaccines. So there’s a lot of excitement about the ...